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Background: Traditionally, pancreatic surgery is considered as one of the most complex surgeries. The
recently developed robotic technology allows surgeons to perform pancreaticoduodenectomy. A
comparative study was undertaken to study outcomes between robotic approach and open approach.
Methods: A consecutive patients underwent pancreaticoduodenectomy (robotic approach, n ¼ 20; open
approach ¼ 67) between January 2000 and February 2012 at a single institution were analyzed.
Results: The robotic group had a signiﬁcantly longer operative time (mean, 491.5 vs. 264.9 min), reduced
blood loss (mean, 247 vs. 774.8 ml), and shorter hospital stay (mean, 13.7 vs. 25.8 days) compared to the
open group. Open conversion rate was 5%. There was no signiﬁcant difference between the two groups in
terms of overall complication rates, mortality rates, R0 resection rate and harvested lymph node
numbers.
Conclusions: This study showed that robot-assisted laparoscopic pancreaticoduodenectomy was safe and
feasible in appropriately selected patients. However, it is too early to draw deﬁnitive conclusions about
the value of robot-assisted laparoscopic pancreaticoduodenectomy. In light of remaining uncertainties
regarding short-term and long-term outcome, caution should be exercised in the assessment of the
appropriateness of this operation for individual patient.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Traditionally, pancreatic surgery is considered as one of the most
complex surgery among the abdominal procedures. This is an opera-
tionwith highmorbidities, typically in the range of 40%.1e3 As a result,
minimally invasive surgery development in pancreatic surgery is also
lag behind that in other gastrointestinal organs. Recently, there has
been growing interest in the ability to perform complex pancreatec-
tomy using the laparoscopic approach. These advanced minimally
invasive surgeries require surgeons to have highly experienced lapa-
roscopic skills. Therefore, the development is slow also. Since the ﬁrst
laparoscopic pancreaticoduodenectomy was reported in 1994, only
limited series of laparoscopic pancreaticoduodenectomy showing
their feasibility, safety, and adequacy have been published.4e8 The
recentlydevelopedsurgical roboticsystemscanovercomemanyof the
limitations and drawbacks of conventional laparoscopic approach.
This may fasten the minimally invasive surgery development of
pancreatectomy. Currently, reports on robot-assisted laparoscopic
pancreaticoduodenectomy are scarce still.9,10ax: þ86 852 2515 3195.
. Lai).
ciates Ltd. Published by Elsevier LtThis nonrandomized comparative study aimed to evaluate the
outcomes between robot-assisted laparoscopic pancreaticoduo
denectomy and open pancreaticoduodenectomy.2. Materials and methods
A consecutive series of patients who underwent robot-assisted laparoscopic
pancreaticoduodenectomy and open pancreaticoduodenectomy for malignant or
benign pathologies at the Department of Surgery, Pamela Youde Nethersole Eastern
Hospital between January 2000 and February 2012 were analyzed. In May 2009, we
started performing robot-assisted laparoscopic pancreatic surgery. From May 2009
to February 2012, 20 patients underwent robot-assisted laparoscopic pan-
creaticoduodenectomy. During this period, two patients with inoperable carcinoma
of pancreas received robot-assisted laparoscopic palliative biliary and gastric bypass
after staging laparoscopy. From January 2000 to February 2012, 67 patients under-
went open pancreaticoduodenectomy.
The da Vinci S Surgical System (Intuitive Surgical Inc., Sunnyvale, CA) was used
for all robot-assisted procedures. Robotic procedures are performed by experienced
surgeons possessing a combination of advanced laparoscopic skills and extensive
experience with open pancreatic surgery. The selection criteria for robot-assisted
laparoscopic pancreaticoduodenectomy was those pancreatic/periampullary
tumors not accompanied by vascular invasion and American Society of Anesthesi-
ologists score (ASA) 3. All patients were informed about the nature of the proce-
dure, and consent was obtained before surgery. The outcome measures included
operating time, blood loss, number of lymph nodes identiﬁed in the surgical spec-
imen, margin of resection, length of post-operative hospital stay, and morbidity and
mortality rates. The deﬁnition of pancreatic ﬁstula was a drain output of anyd. All rights reserved.
Fig. 2. Clipping of gastroduodenal artery.
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greater than 3 times the serum amylase activity.
2.1. Procedure for robot-assisted laparoscopic pancreaticoduodenectomy
The patient is placed on a split-leg table in the supine position. The patient is
positioned in reverse Trendelenberg position. The robotic system is positioned at the
head of the patient, and the assistant surgeon is positioned at the side of patient. The
operation begins with a staging laparoscopy and laparoscopic ultrasound using a 12-
mm trocar placed in the sub-umbilical site. If no distant metastases or portal vein/
superior mesenteric vein invasion, the remaining trocars (one assistant port 12 mm
and three 8 mm ports) are placed. Port placement is illustrated in Fig. 1. The camera
is placed in the sub-umbilical port. All the rest three arms of the robot are utilized,
with the third robotic arm used for retraction and exposure. The assistant 12 mm
port allows the assistant surgeon to pass needles, and manage the suction-irrigator,
clip appliers, and endostapler as needed.
Cholecystectomy is performed ﬁrst. The hepatic ﬂexure is then mobilized. A
wide Kocher maneuver is also performed with mobilizing the transverse duodenum
from the ligament of Trietz from the right side of the table beneath the mesenteric
vessels. After Kochermaneuver is completed, the common bile duct is freed from the
portal vein and the hepatic artery. The bile duct is transected higher above the cystic
duct junction. The common hepatic artery is identiﬁed and dissected, followed by
dissection and ligation of the gastroduodenal artery. The gastroduodenal artery is
double clipped and divided near its origin (Fig. 2). Porta lymph node dissection was
performed also.
After portal dissection, the distal stomach is identiﬁed and cleared of mesentery
along its greater and lesser curves with the Ligasure (Covidien, Boulder, CO, USA).
The nasogastric tube is withdrawn, and the stomach is transected with an endo-
stapler (Covidien, Norwalk, CT, USA). The proximal jejunum segment is then iden-
tiﬁed. The proximal jejunal loop is prepared by further mobilizing the ligament of
Treitz, and several vessels are taken with the coagulative scissors and Ligasure
(Fig. 3). The jejunum is divided distal to the ligament of Treitz using an endostapler.
The greater omentum is incised to allow entry into the omental bursa. The
anterior plane of the superior mesenteric vein is exposed, and the tissue between
this plane and the dorsal plane of the pancreas is freed, followed by tunneling
between the pancreas and the portal vein (Fig. 4). The tunneled pancreas is then
transected (Fig. 5). The pancreas is mobilized from the lateral border of the superior
mesenteric vein (SMV)-portal vein working in a caudal to cephalic direction.
As in open approach, upon completion of the pancreaticoduodenectomy, the
proximal 2e3 cm of the pancreatic body remnant was mobilized in preparation for
the pancreaticojejunostomy (PJ) anastomosis. The dissected segment of the
jejunum is pulled out from the dorsal plane of the mesentery to the right side. PJ
anastomosis, hepaticojejunostomy, and gastrojejunal anastomosis are performed in
this order. If the pancreatic duct is small (</ ¼ 3 mm), 2-layers end-to-side
dunking technique of PJ anastomosis is performed. If the pancreatic duct is
dilated (>3 mm), 2-layers end-to-side duct-to-mucosal anastomotic technique
(Fig. 6) is performed. Internal pancreatic ductal stenting is used. The stent is not
secured. The reconstruction is completed in each patient using an end-to-side
hepaticojejunostomy (Fig. 7), and a side-to-side gastrojejunostomy. The specimen
is extracted into an endobag through a Pfannenstiel incision. Two silicone drains
are placed near pancreaticojejunostomy and hepatico-jejunsotomy at the end of
the procedure.Fig. 1. Port site.2.2. Statistical method
Continuous variables were expressed as mean  standard deviation (SD) and
were compared using the Student’s t test. Categorical variables were compared using
the c2 test or Fisher’s exact test. p-Value less than 0.05 was considered statistically
signiﬁcant.
3. Results
During the study period, 20 patients underwent robot-assisted
laparoscopic pancreaticoduodenectomy and 67 patients under-
went open pancreaticoduodenectomy. The two groups were well
matched for age, gender, tumor size, pathologies, and type of
anastomoses. Demographic characteristics of the patients, and
operative details were shown in Table 1. Malignant cases accounted
for 75% of patients in the robotic group and 79.1% of patients in the
open group. Both groups had no vascular invasion identiﬁed at time
of surgery.
Intraoperative and post-operative outcomes were shown in
Table 2. The robotic group had a signiﬁcantly longer operative time
(mean, 491.5 vs. 264.9 min), reduced blood loss (mean, 247 vs.
774.8 ml), and a shorter hospital stay (mean, 13.7 vs. 25.8 days)
compared to theopengroup. In the robotic group, theoperating time
of the ﬁrst 10 and the second 10 patients was analyzed. There were
no signiﬁcant differences (521.1  122.9 min vs. 461.9  40 min)
(p ¼ 0.16).Fig. 3. Mobilization of proximal jejunum.
Fig. 6. Pancreaticojejunostomy (duct-to-mucosa approach).
Fig. 4. Tunneling between pancreatic neck and portal vein.
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surgery (5%) because of difﬁculties in dissecting the pancreatic
head and neck from the SMV/portal vein in a patient with chronic
pancreatitis. There was no signiﬁcant difference between the two
groups in terms of overall complication rates (50 vs. 49.3%),
mortality rates (0 vs. 3%). The length of post-operative stay for the
robotic group was signiﬁcantly shorter than for the open group
(mean, 13.7 vs. 25.8 days).
Seven patients in robotic group developed PJ leakages/ﬁstulas,
representing 35%. All weremanaged conservatively with octreotide
and antibiotics coverage. This meant simply keeping the drains in
place and measuring the output on a daily outpatient basis. This
group of patients, except one mentioned below, did not require
further surgical treatment, and the drains were removed when
output was minimal. In the open group, 12 patients (17.9%) devel-
oped PJ leakages/ﬁstulas, and only one of the 12 patients needed
reoperation due to PJ leakages/ﬁstulas.
A total of 2 patients in the robotic group required reoperation.
One patient suffered from pseudoaneurysm over replaced right
hepatic artery due to infective complication of PJ leakage/ﬁstula.
Transarterial embolization was failed. Open exploration for hemo-
stasis was performed. The other patient was reoperated for right
ascending colon ischemia due to inadvertent injury to its blood
supply. Right hemi-colectomy was performed.
Pathology outcomes were shown in Table 1.Fig. 5. Transection of pancreatic neck.4. Discussion
Pancreaticoduodenectomy remains the greatest challenge for
pancreatic surgeons and entails not only extensive dissection
around major blood vessels but also the formation of complex and
multiple anastomoses. Recently, Gumbs et al. reviewed 285
patients underwent conventional laparoscopic pan-
creaticoduodenectomy reported in the medical literature so far.10
87% were performed totally laparoscopically, and 13% were per-
formed with a hand-assisted approach. The rate of conversion to an
open procedure was 9%. Estimated blood loss was 189 ml. Average
length of stay was 12 days. The overall complication rate was 48%,
and the overall mortality rate was 2%. Average lymph nodes
retrieved ranged from 7 to 36 nodes, with a mean of 15 nodes, and
positive margins of resectionwere reported to be positive in 0.4% of
patients with malignant disease. It should be noted that all these
patients were highly selected and operated in expert center. The
data in these series were difﬁcult to interpret because of the het-
erogenicity of the pathologies and techniques used. So far, only two
studies available comparing laparoscopic and open pan-
creaticoduodenectomy.11,12 All these results failed to demonstrate
clear advantages over open pancreaticoduodenectomy. Despite
these advances and the reports of early series with the complexity
of the surgery the majority of pancreatic surgeons are still not
convinced of its potential beneﬁts. In addition, due to the technicalFig. 7. Hepaticojejunostomy.
Table 1
Details of patient, operation and pathology.
Variables (n) Robotic
approach
(n ¼ 20)
Open approach
(n ¼ 67)
p-value
Age, mean  SD 66.4  11.9 62.1  11.2 0.13
Gender (male/female) 12 (60%)/
8 (40%)
38 (56.7%)/
29 (43.3%)
0.79
ASA score 0.20
1 4 (20%) 5 (7.5%)
2 16 (80%) 62 (92.5%)
3 0 (0%) 0 (0%)
Malignant pathology 0.70
Ca pancreas 7 (35%) 24 (35.8%)
Cholangiocarcinoma 1 (5%) 10 (14.9%)
Ca ampulla 5 (25%) 14 (20.9%)
IPMN 1 (5%) 2 (3%)
Duodenal GIST 1 (5%) 2 (3%)
Neuroendocrine tumor 0 (0%) 1 (1.5%)
Benign pathology
Neuroendocrine tumor 0 (0%) 2 (3%)
Ca ampulla in-situ 1 (5%) 0 (0%)
Chronic pancreatitis 1 (5%) 2 (3%)
IgG4 autoimmune pancreatitis 0 (0%) 1 (1.5%)
Solid pseudopapillary neoplasm 1 (5%) 0 (0%)
IPMN 0 (0%) 2 (3%)
Serous cystic adenoma 1 (5%) 2 (3%)
Villous tubular adenoma 1 (5%) 1 (1.5%)
Adenomyomatous inﬂammation 0 (0%) 4 (6%)
Tumor size (cm) 2.1  0.7 2.9  2.3 0.15
Whipple’s operation 20 (100%) 63 (94%) 0.26
Pylorus preserving
pancreatico-duodenectomy
0 (0%) 4 (6%)
Pancratico-jejunostomy 20 (100%) 65 (97%) 0.43
Pancratico-gastrostomy 0 (0%) 2 (3%)
Duct-to-mucosa anastomotic
technique
17 (85%) 47 (70.1%) 0.18
Dunking anastomotic technique 3 (15%) 20 (29.9%)
Mean lymph node harvested 10  6 10  8 0.99
R0 resection rate in malignant
pathology
11 (73.3%) 34 (64.1%) 0.92
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centers have adopted this minimally invasive approach. Indeed, we
also agree that there is a long learning curve for this complex
procedure, although the number of cases that need to pass this
learning curve is still not known. In our study, there was no
signiﬁcant difference in the operating time between the ﬁrst 10 and
second 10 patients. The possible reason is that before the robotic
system installation in our unit, we have accumulated certainTable 2
Intraoperative and post-operative outcome.
Variables (n) Robotic
approach
(n ¼ 20)
Open approach
(n ¼ 67)
p-value
Mean operating time (min) 491.5  94 264.9  63.7 0.01
Mean blood loss (ml) 247 (50e889) 774.8 (50e8000) 0.03
Open conversion 1 (5%) \ \
Number of patients
with complication
10 (50%) 33 (49.3%) 0.95
Overall complication
Pancreatic ﬁstula 7 (35%) 12 (17.9%) 0.11
Bile leakage 3 (15%) 4 (6%) 0.19
Post-operative hemorrhage 2 (10%) 3 (4.5%) 0.04
Intra-abdominal collection/abscess 2 (10%) 9 (13.4%) 0.69
Bowel ischemia 1 (5%) 0 (0%) 0.06
SMV thrombosis 0 (0%) 1 (1.5%) 0.58
Delayed gastric emptying 1 (5%) 8 (11.9%) 0.37
Wound infection 1 (5%) 4 (6%) 0.87
Reoperation rate 2 (10%) 3 (4.5%) 0.04
Post-operative death 0 (0%) 2 (3%) 0.43
Mean post-operative
hospital stay (days)
13.7  6.1 25.8  23.1 0.02experience and skills in 10 hand-assisted laparoscopic pan-
creaticoduodenectomies. Therefore, when we adopted the tech-
nique of robotic approach, the difﬁculties would be less than usual.
Conventional laparoscopic surgery has its own limitations,
including reduced freedom of movement within the abdominal
cavity and 2-dimensional view of a 3-dimensional operative ﬁeld.
In addition, the laparoscopic instruments provide surgeons with
reduced precision and poor ergonomics. These limitations translate
into a long learning curve, requiring a lot of time and effort to
develop and maintain such advanced laparoscopic skills. These
shortcomings of laparoscopic surgery were the impetus behind the
development of robotic surgery. Robotic surgery is the latest tech-
nological advance in minimally invasive surgery. Its future imple-
mentation will depend on the advantages that it can provide over
conventional laparoscopy or open surgery. They increase dexterity,
restore proper hand-eye coordination and an ergonomic position,
and improve visualization.13,14 Several steps of the pancreatectomy
may be improved with robotic surgery, including dissection of the
pancreatic gland from major vasculatures, lymph node dissection,
dissection and resection of the uncinate process, and reconstruc-
tion of anastomoses. The procedure emphasizes teamwork
between two experienced pancreatic surgeons and requires a four-
handed technique for appropriate retraction and exposure of crit-
ical structures. However, there are also several disadvantages to
these systems. First of all, robotic surgery is a new technology and
its uses and efﬁcacy have not yet been well established. Another
disadvantage of these systems is their cost.
To the best of our knowledge, only three studies have been
published comparing the robotic approach and the open approach
for pancreaticoduodenectomy.15e17 No randomized trial has been
reported. Zhou et al. from Beijing, China showed robotic group
(n ¼ 8) had a signiﬁcantly longer operating time (718 vs. 420 min),
reduced blood loss (153 vs. 210ml), and a shorter hospital stay (16.4
vs. 24.3 days) compared to the open group (n ¼ 8).15 Robotic group
had a signiﬁcantly lower complication rate (25 vs. 75%). There was
no signiﬁcant difference in mortality rate (0 vs. 12.5%) and R0
resection rate (100 vs. 83.3%). Buchs et al. from Chicago, US showed
that robotic group (n ¼ 44) had a signiﬁcantly shorter operating
time (444 vs. 559 min), reduced blood loss (387 vs. 827 ml)
compared to the open group (n ¼ 39).16 There was no signiﬁcant
difference in complication (36.4 vs. 48.7%), and mortality rate (4.5
vs. 2.6%). A higher number of lymph nodes harvested (16.8 vs. 11) in
robotic group. There was no signiﬁcant difference in R0 resection
rate (90.9 vs. 81.5%). Chalikonda et al. from Cleveland, US showed
that robotic approach (n ¼ 30) had a signiﬁcant longer operating
time (476.2 vs. 366.4 min) but decreased length of stay (9.79 vs.
13.26 days) compared to the open group (n ¼ 30).17 There was no
signiﬁcant difference in complication (30 vs. 43%), and mortality
rate (4 vs. 0%). There was no signiﬁcant difference in number of
lymph nodes harvested (13.2vs. 11.76). Robotic group had a higher
R0 resection rate (100 vs. 87%). Our study showed similar outcome
to these studies. When compared to open approach, robotic
approach was associated with a signiﬁcantly longer operating time,
reduced blood loss, and a shorter hospital stay. There was no
signiﬁcant difference in complication rate, mortality rate, R0
resection rate and number of harvested lymph nodes.
The current role ofminimally invasive pancreaticoduodenectomy
is unclear when compared with other advanced abdominal proce-
dures. It is a complex abdominal operationwith high morbidity, the
majority of which is not attributable to the surgical wound. Pancre-
atic ﬁstula/anastomotic leakage remain the single most important
morbidity after pancreaticoduodenectomy and contribute to pro-
longed hospitalization and mortality.3 All the reported series,
including our study, showed that robotic approach failed to decrease
the rate of pancreatic ﬁstula/anastomotic leakage. In the present
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approach. In our study, the robotic group had a statistically non-
signiﬁcant higher pancreatic ﬁstula rate and a signiﬁcantly higher
reoperation rate. Partof the reasonmightbedue to the learningcurve
issue.With the small numberof patients in the robotic group, it is still
too early to draw any conclusion. Hopefully, with more experience,
the complication ratewill be lower.We have also analyzed the cause
of difference in hospital stay in both groups in our study. The main
reason was due to the prolong hospital stay in those patients with
complications in theopengroup. In the16patientswithpancreatic or
biliary ﬁstula in the open group, 13 patients had stay in the hospital
more than 1 month time. In addition, there are also some concerns
with regard to its application and the prolonged surgery time
required. For example, the appropriateness of its application for
oncologic resection has not been thoroughly established. Based on
the current evidence, despite technical feasibility of robot-assisted
laparoscopic pancreaticoduodenectomy, in the absence of obvious
deﬁnitive advantages over the open approach, and in light of
remaining uncertainties regarding long-term oncologic outcome,
caution shouldbe exercised in the assessmentof the appropriateness
of this operation for individual patient.
In conclusion, robotic-assisted laparoscopic pancreaticoduo
denectomy is feasible and safe in appropriately selected patients.
However, it should only be performed by surgeons experienced with
traditional open pancreaticoduodenectomy and other advanced
laparoscopic surgery. It is still too early to draw deﬁnitive conclusions
concerning the value of robot-assisted laparoscopic pancreatico
duodenectomy. Prospective randomized studies with a greater
number of cases are needed to conﬁrm its role.
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